Status:
COMPLETED
Proton Radiation Therapy for Macular Degeneration
Lead Sponsor:
University of Florida
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This is a pilot study to determine if proton radiation therapy can provide effective and safe treatment for subfoveal neovascularization membrane (SNVM). The study will include adult patients over the...
Detailed Description
As part of this study, participants will have had a standard of care comprehensive eye exam by an Ophthalmologist to include visual acuity, fundus photography, fluorescein angiography and optical cohe...
Eligibility Criteria
Inclusion
- Patients with subfoveal neovascular membranes identified on fluorescein angiography.
- Visual acuity (best corrected vision) 20/200 or worse in affected eye.
- Patient must be 50 years of age or older at time of consent.
- Patients must have had prior treatment for macular degeneration with Avastin (bevacizumab) or Lucentis (ranibizumab).
- Women must be post menopausal or have had a hysterectomy.
Exclusion
- History of diabetes.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01833325
Start Date
May 1 2013
End Date
February 1 2018
Last Update
February 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States, 32206